|
Acadia Pharmaceuticals
|
16.61 |
|
-0.46 |
-2.69% |
-9.04% |
2025-03-31 |
|
Agios Pharmaceuticals
|
29.28 |
|
-1.00 |
-3.30% |
1.46% |
2025-03-31 |
|
ALKERMES
|
32.64 |
|
-0.57 |
-1.72% |
19.82% |
2025-03-31 |
|
Amgen
|
312.21 |
|
5.01 |
1.63% |
10.31% |
2025-03-31 |
|
Arrowhead Research
|
12.74 |
|
-1.08 |
-7.81% |
-54.89% |
2025-03-31 |
|
Biogen
|
136.97 |
|
-1.48 |
-1.07% |
-36.24% |
2025-03-31 |
|
BioMarin Pharmaceutical
|
70.66 |
|
-0.78 |
-1.09% |
-18.87% |
2025-03-31 |
|
Clal Biotechnology
|
33.50 |
|
-0.30 |
-0.89% |
-19.28% |
2025-03-27 |
|
Compugen
|
567.60 |
|
9.40 |
1.68% |
-39.46% |
2025-03-27 |
|
Cipla
|
1,442.20 |
|
-40.70 |
-2.74% |
-3.77% |
2025-03-28 |
|
CSL
|
249.28 |
|
-3.44 |
-1.36% |
-13.03% |
2025-03-31 |
|
Cytokinetics
|
40.52 |
|
-2.67 |
-6.18% |
-44.51% |
2025-03-31 |
|
Gilead Sciences
|
112.18 |
|
0.34 |
0.30% |
53.92% |
2025-03-31 |
|
Grifols
|
7.12 |
|
-0.15 |
-2.06% |
6.59% |
2025-03-31 |
|
GlaxoSmithKline
|
1,462.00 |
|
-26.50 |
-1.78% |
-12.09% |
2025-03-31 |
|
Halozyme Therapeutics
|
63.68 |
|
-0.16 |
-0.25% |
54.11% |
2025-03-31 |
|
Insmed
|
76.23 |
|
-1.76 |
-2.26% |
185.29% |
2025-03-31 |
|
Ligand Pharmaceuticals
|
104.94 |
|
-2.68 |
-2.49% |
42.58% |
2025-03-31 |
|
MannKind
|
5.01 |
|
-0.03 |
-0.50% |
15.32% |
2025-03-31 |
|
Merck
|
126.60 |
|
-3.95 |
-3.03% |
-19.72% |
2025-03-31 |
|
Moderna
|
28.35 |
|
-2.77 |
-8.90% |
-73.16% |
2025-03-31 |
|
Neurocrine Biosciences
|
111.16 |
|
-2.00 |
-1.77% |
-21.38% |
2025-03-31 |
|
Novartis
|
97.84 |
|
-0.78 |
-0.79% |
14.17% |
2025-03-31 |
|
Pfizer
|
25.35 |
|
0.16 |
0.64% |
-8.55% |
2025-03-31 |
|
Ultragenyx Pharmaceutical
|
36.46 |
|
-1.36 |
-3.60% |
-22.38% |
2025-03-31 |
|
Sanofi
|
101.92 |
|
-1.48 |
-1.43% |
15.12% |
2025-03-31 |
|
Teva Pharmaceutical Industries
|
5,587.00 |
|
7.00 |
0.13% |
7.63% |
2025-03-31 |
|
Vertex Pharmaceuticals
|
484.93 |
|
-7.42 |
-1.51% |
15.33% |
2025-03-31 |